Somatostatin and its analogs have been for years a mainstay treatment for a variety of hypersecretory conditions and neoplasms of the endocrine system. This chapter summarizes their pharmacological properties, their indication in the context of acromegaly, and the best way to handle this class of drugs for the treatment of the patient with acromegaly.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000539990 | DOI Listing |
Publication Analysis
Top Keywords
treatment long-acting
4
long-acting somatostatin
4
somatostatin analogues
4
analogues patients
4
patients acromegaly
4
acromegaly somatostatin
4
somatostatin analogs
4
analogs years
4
years mainstay
4
mainstay treatment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!